GT 00X - Evotec/Glycotope
Alternative Names: GT-00X - Evotec/Glycotope; GT-00X bispecific - Evotec/GlycotopeLatest Information Update: 03 Jan 2024
At a glance
- Originator Glycotope
- Developer Evotec SE; Glycotope
- Class Antineoplastics; Bispecific antibodies; Immunotherapies
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours